TapewireFind a company

person · Reporting owner

Herzog David L

Disclosed activity across 4 companies

Tapewire entity
25858
SEC CIK
0001331793

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AEGON LTD.AEG · Entity 3394DirectorSeptember 24, 2026September 28, 2026
DXC Technology CoDXC · Entity 4594DirectorAugust 04, 2026August 06, 2026
METLIFE INCMET · Entity 488DirectorApril 01, 2025April 03, 2025
OCTAVE SPECIALTY GROUP INCAMBC · Entity 6308DirectorApril 03, 2023April 04, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AEGON LTD.

Report date September 24, 2026 · Filed September 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect24,985 Reported balance After 2026-09-24 transaction · row 1
1 source row

Row 1 · 2026-09-24 · Grant · Acquired 257 · Balance 24,985

F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards.

DXC Technology Co

Report date August 04, 2026 · Filed August 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect147,301 Reported balance After 2026-08-04 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-08-04 · Grant · Acquired 30,900 · Balance 147,301

F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2: Amount reported includes unvested RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2: Amount reported includes unvested RSUs.

METLIFE INC

Report date April 01, 2025 · Filed April 03, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect26,138 Reported balance After 2025-04-01 transaction · row 1
1 source row

Row 1 · 2025-04-01 · Grant · Acquired 218 · Balance 26,138

F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

F2: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board.

Common StockSEC Table I · non-derivativeIndirectby David L. Herzog Trust87 Reported balance Holding disclosure · report date 2025-04-01 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 87

Filing footnotes · ownership attribution and instrument terms

F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

F2: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board.

OCTAVE SPECIALTY GROUP INC

Report date April 03, 2023 · Filed April 04, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect93,057 Reported balance After 2023-04-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2023-04-03 · Grant · Acquired 3,277 · Balance 93,057

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 10, 2021 Filed Nov 12, 2021 13:45 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 3,051 $0.00 $0.00
Disclosure

SEC source: 0000874501-21-000159 · wf-form4_163672474353898.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,632

Underlying: Common Stock · 3,051 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on November 10, 2021 shall vest one year later on November 10, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on November 10, 2021 shall vest one year later on November 10, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 20:32 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 600 $62.52 $37,512.00
Disclosure

SEC source: 0001099219-21-000324 · wf-form4_163346592525200.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,214

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 20:37 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 43 $60.78 $2,613.54
Disclosure

SEC source: 0001099219-21-000289 · wf-form4_163182463983085.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,614

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 21:30 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 5,600 $0.00 $0.00
Disclosure

SEC source: 0001688568-21-000066 · wf-form4_162984059887690.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,706

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
August 09, 2021 Filed Aug 10, 2021 20:09 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 3,437 $0.00 $0.00
Disclosure

SEC source: 0000874501-21-000133 · wf-form4_162862613960335.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,581

Underlying: Common Stock · 3,437 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on August 9, 2021 shall vest one year later on August 9, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on August 9, 2021 shall vest one year later on August 9, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:13 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 589 $63.77 $37,560.53
Disclosure

SEC source: 0001099219-21-000243 · wf-form4_162396434125807.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,571

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
June 14, 2021 Filed Jun 17, 2021 00:56 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 41 $63.31 $2,595.71
Disclosure

SEC source: 0001099219-21-000211 · wf-form4_162389137119693.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,982

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
May 12, 2021 Filed May 12, 2021 20:10 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 2,936 $0.00 $0.00
Disclosure

SEC source: 0000874501-21-000089 · wf-form4_162085024078071.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,144

Underlying: Common Stock · 2,936 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on May 12, 2021 shall vest one year later on May 12, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on May 12, 2021 shall vest one year later on May 12, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:50 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 609 $61.60 $37,514.40
Disclosure

SEC source: 0001099219-21-000156 · wf-form4_161765579714384.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,942

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:56 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 41 $60.54 $2,482.14
Disclosure

SEC source: 0001099219-21-000124 · wf-form4_161601456915406.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,333

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 21:25 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 814 $46.08 $37,509.12
Disclosure

SEC source: 0001099219-21-000026 · wf-form4_160988188363660.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,292

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
December 14, 2020 Filed Dec 16, 2020 22:07 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 53 $45.84 $2,429.52
Disclosure

SEC source: 0001099219-20-000382 · wf-form4_160815641588069.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,478

F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 21:39 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 1,007 $37.26 $37,520.82
Disclosure

SEC source: 0001099219-20-000345 · wf-form4_160193392776134.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,425

F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
September 14, 2020 Filed Sep 16, 2020 20:26 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 62 $38.84 $2,408.08
Disclosure

SEC source: 0001099219-20-000314 · wf-form4_160028798229966.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,418

F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
August 18, 2020 Filed Aug 20, 2020 22:23 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 10,300 $0.00 $0.00
Disclosure

SEC source: 0001688568-20-000068 · wf-form4_159796217923295.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,106

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 20:50 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 970 $38.69 $37,529.30
Disclosure

SEC source: 0001099219-20-000270 · wf-form4_159251341407130.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,356

F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 20:57 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 63 $37.45 $2,359.35
Disclosure

SEC source: 0001099219-20-000236 · wf-form4_159234102229723.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,386

F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
April 30, 2020 Filed May 1, 2020 20:10 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 11,628 $0.00 $0.00
Disclosure

SEC source: 0000874501-20-000066 · wf-form4_158836380645066.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,208

Underlying: Common Stock · 11,628 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on April 30, 2020 shall vest one year later on April 30, 2021. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on April 30, 2020 shall vest one year later on April 30, 2021. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
April 01, 2020 Filed Apr 2, 2020 21:19 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 1,345 $27.90 $37,525.50
Disclosure

SEC source: 0001099219-20-000176 · wf-form4_158586236348085.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,323

F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
March 13, 2020 Filed Mar 18, 2020 01:12 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 70 $31.93 $2,235.10
Disclosure

SEC source: 0001099219-20-000158 · wf-form4_158449395130755.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,978

F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:49 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000040 · wf-form4_157834732576594.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,908

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:49 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 44 $50.38 $2,216.72
Disclosure

SEC source: 0001099219-19-000253 · wf-form4_157661935347865.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,181

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000208 · wf-form4_157013556720627.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,137

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:46 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 38 $48.37 $1,838.06
Disclosure

SEC source: 0001099219-19-000167 · wf-form4_156875319746296.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,322

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
August 20, 2019 Filed Aug 21, 2019 22:27 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 6,500 $0.00 $0.00
Disclosure

SEC source: 0001688568-19-000094 · wf-form4_156642644491247.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,406

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
August 20, 2019 Filed Feb 28, 2020 21:57 UTC Amendment DXC Technology Co DXC · Entity 4594 GrantCommon Stock 5,900 $0.00 $0.00
Disclosure

SEC source: 0001688568-20-000010 · wf-form4a_158292703596064.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,806

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2 · shares: This Form 4 is being amended to correct the number of RSUs awarded from 6,500 RSUs to 5,900 RSUs.

F3 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:52 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000119 · wf-form4_156106392570998.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,284

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 22:55 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 31 $48.51 $1,503.81
Disclosure

SEC source: 0001099219-19-000070 · wf-form4_156081211961898.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,514

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
April 30, 2019 Filed May 1, 2019 20:54 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 10,696 $0.00 $0.00
Disclosure

SEC source: 0000874501-19-000052 · wf-form4_155674404091705.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,580

Underlying: Common Stock · 10,696 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on April 30, 2019 shall vest one year later on April 30, 2020. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on April 30, 2019 shall vest one year later on April 30, 2020. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
April 01, 2019 Filed Apr 2, 2019 20:39 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 850 $44.13 $37,510.50
Disclosure

SEC source: 0001209191-19-022551 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,483

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
March 13, 2019 Filed Mar 14, 2019 20:38 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 24 $44.70 $1,072.80
Disclosure

SEC source: 0001209191-19-019468 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,633

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 21:30 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 900 $41.67 $37,503.00
Disclosure

SEC source: 0001209191-19-001973 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,609.2856

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:23 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 16.9965 $39.52 $671.70
Disclosure

SEC source: 0001209191-18-062723 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,709.2856

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:29 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054009 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,692.2891

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:49 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 7.2891 $45.52 $331.80
Disclosure

SEC source: 0001209191-18-051226 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,890.2891

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
August 20, 2018 Filed Aug 22, 2018 23:48 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 2,300 $0.00 $0.00
Disclosure

SEC source: 0001688568-18-000100 · wf-form4_153498168907553.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,906

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2 · balance_after: Amount reported includes unvested RSUs.

F3 · balance_after: Pursuant to the anti-dilution provisions of the registrant's 2017 Non-Employee Director Incentive Plan, the amount of securities beneficially owned has been adjusted in connection with the spin-off of the registrant's United States Public Sector business. A conversion ratio of 0.8649 was applied to the August 15, 2017 award of 2,300 RSUs (the "2017 Award") that remained unvested at the time of the spin-off. As a result, the reporting person received 359 additional RSUs. The 2017 Award vested in full on August 15, 2018.

Read SEC document
June 12, 2018 Filed Jun 14, 2018 20:41 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 790 $47.49 $37,517.10
Disclosure

SEC source: 0001209191-18-037748 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,883

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
April 30, 2018 Filed May 1, 2018 21:23 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 11,744 $0.00 $0.00
Disclosure

SEC source: 0000874501-18-000051 · wf-form4_152520982192112.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,884

Underlying: Common Stock · 11,744 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on April 30, 2018 shall vest one year later on April 30, 2019. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on April 30, 2018 shall vest one year later on April 30, 2019. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 20:23 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 833 $45.02 $37,501.66
Disclosure

SEC source: 0001209191-18-023635 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,093

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
January 02, 2018 Filed Jan 4, 2018 21:18 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 748 $50.18 $37,534.64
Disclosure

SEC source: 0001209191-18-001931 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,260

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:18 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055805 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,512

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock.

Read SEC document
August 15, 2017 Filed Aug 17, 2017 20:42 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 2,300 $0.00 $0.00
Disclosure

SEC source: 0001688568-17-000189 · wf-form4_150300255477349.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,247

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders.

F1 · price: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
August 10, 2017 Filed Aug 14, 2017 20:55 UTC DXC Technology Co DXC · Entity 4594 Exercise / conversionRestricted Stock Units · Derivative 900 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001688568-17-000172 · wf-form4_150274411544163.xml · derivative · entry 2

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs vested and settled at the annual meeting of stockholders held on August 10, 2017.

F1 · derivative.expiration_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs vested and settled at the annual meeting of stockholders held on August 10, 2017.

Read SEC document
August 10, 2017 Filed Aug 14, 2017 20:55 UTC DXC Technology Co DXC · Entity 4594 Exercise / conversionCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001688568-17-000172 · wf-form4_150274411544163.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 947

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs vested and settled at the annual meeting of stockholders held on August 10, 2017.

Read SEC document
June 13, 2017 Filed Jun 15, 2017 20:19 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 704 $53.31 $37,530.24
Disclosure

SEC source: 0001209191-17-040123 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,792

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock.

Read SEC document
May 15, 2017 Filed May 17, 2017 21:53 UTC DXC Technology Co DXC · Entity 4594 GrantRestricted Stock Units · Derivative 900 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001688568-17-000073 · wf-form4_149505797656313.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 900 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders.

F1 · derivative.expiration_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders.

Read SEC document
April 28, 2017 Filed May 1, 2017 21:44 UTC OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 GrantRestricted Stock Units · Derivative 10,294 $0.00 $0.00
Disclosure

SEC source: 0000874501-17-000048 · wf-form4_149367507158519.xml · derivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,140

Underlying: Common Stock · 10,294 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

F2 · derivative.exercise_date: RSU's granted on April 28, 2017 shall vest one year later on April 30, 2018. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

F2 · derivative.expiration_date: RSU's granted on April 28, 2017 shall vest one year later on April 30, 2018. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Read SEC document
October 21, 2016 Filed Oct 25, 2016 20:18 UTC METLIFE INC MET · Entity 488 GrantCommon Stock 2,088 $46.38 $96,841.44
Disclosure

SEC source: 0001209191-16-146859 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,088

F1 · kind: Under the Company's Non-Management Director Stock Compensation arrangements, 50% of the Annual Retainer Fee is paid in the Company's common stock. This is a pro rata amount for the period starting October 21, 2016 and ending June 12, 2017.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.